Exercise slashes risk of death in patients with colon cancer
Physical activity could also prevent the disease from coming back, as well as lifting mood, reducing fatigue and boosting strength, according to researchers.
Colon cancer develops in the part of the large intestine known as the colon, part of the large bowel, which also comprises the rectum and anus.
It can sometimes be referred to as bowel cancer or colorectal cancer.
Cancer Research UK estimates about 31,800 people every year in the UK are diagnosed with the disease, with around 9,500 deaths.
The CO21 Challenge trial, led by researchers in Northern Ireland and Canada, involved 889 people with colon cancer from six countries, including the UK.
All patients had had surgery and chemotherapy for their cancer and were deemed well enough to exercise, but were not meeting recommended physical activity levels.
Around half were given a three-year tailored exercise programme, which included the likes of brisk walking, circuit classes, cycling, or swimming.
The plan included in-person coaching sessions for the first six months, as well as regular meetings with a physical activity consultant.
The other group were offered materials that promoted exercise and nutrition.
The study found that after five years, the risk of dying, relapse or developing a new cancer was 28% lower in the group with a tailored exercise plan.
After eight years, patients in the physical activity group had a 37% lower risk of death.
Professor Vicky Coyle, UK lead researcher for the trial and clinical professor at Queen's University Belfast, said: 'During the trial, we supported people to reach their weekly exercise target in a way that worked for them.
'This could be a brisk walk for around 40 minutes every day, but some patients were also doing circuit classes, cycling, swimming, and many other activities.
'Our study gives clear, encouraging evidence that physical activity can reduce the risk of cancer returning for some people with colon cancer.
'We now need to work with policymakers and healthcare providers to embed exercise into treatment plans where appropriate.'
Dr Joe Henson, associate professor in lifestyle medicine at the University of Leicester, said: 'Leading the exercise sessions in Leicester, I saw first-hand that this reduced fatigue, lifted people's mood, and boosted their physical strength.
'We know that physical activity regulates several key biological processes that could explain these results, and further research will help us uncover why exercise is having such a positive impact.'
The findings, published in the New England Journal of Medicine and presented at the American Society of Clinical Oncology (ASCO), could 'transform clinical practice', according to experts.
Caroline Geraghty, senior specialist information nurse at Cancer Research UK, which part-funded the CO21 Challenge through Stand Up To Cancer, said: 'Being active has many benefits, and this study shows that exercise doesn't only improve well-being – it can also boost people's chances of surviving colon cancer.
'Everyone recovering from cancer should have access to tailored support to help them live longer, better lives.
'This trial has the potential to transform clinical practice, but only if health services have the necessary funding and staff to make it a reality for patients.
'It's important to remember that every cancer journey is different – starting new activities after treatment can feel overwhelming, and it may not be the right option for everyone. Take things at your own pace and speak to your doctor to discuss what is safe for you.'
Professor Peter Johnson, NHS national clinical director for cancer, said: 'These exciting findings add to the growing evidence of the benefits of physical activity for people affected by cancer, not just in helping them be fitter for treatment and boosting their immediate recovery, but reducing the risk of the disease coming back.
'This is why we've asked cancer alliances across the country to look at ways to encourage and support patients to do physical activity and ensure every healthcare professional they see can help them be in the best possible place – both physically and mentally – before, during and after treatment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
11 hours ago
- The Guardian
One in three overdue for cervical cancer screening across UK
A third of people across the UK are overdue their cervical cancer screening, while in parts of England some are at greater risk of the disease than others due to a low uptake for the preventive vaccine, experts have warned. Since the coronavirus pandemic, cervical screening attendance rates have been steadily declining, from 72.2% in 2020 to 68.4% in 2024, NHS England data shows. A YouGov survey of 3,000 people across the UK eligible for cervical cancer screening, commissioned by Cancer Research UK, is in line with these findings, with 30% of respondents being overdue their screening. It also highlighted the main barriers people cited, with 42% of respondents finding cervical screening painful previously, 40% not wanting a man to carry out the screening test, and just under one in five (19%) of respondents saying they were too embarrassed to go for a screening. Of those who did not attend their screening, 16% of respondents said it was because they didn't have any symptoms, highlighting the misinformation still prevalent regarding cervical screening, which is for people without symptoms. Separate figures from the UK Heath Security Agency (UKHSA) have found that uptake of the HPV vaccine greatly varies by region, with girls in London by year 10 having the lowest uptake (64.9%) and girls in the south-east the highest (82.7%). Among boys of the same age, it was also lowest in London (58.9%) and highest in the south-east (77.3%). HPV refers to a group of viruses that can be transmitted through sexual contact and cause no symptoms. About 13 high-risk types of HPV are known to cause 99.7% of cervical cancers. Each year, about 3,200 women in the UK are diagnosed with cervical cancer and 850 die from it. It is the 14th most common cancer affecting women in Britain, with women aged 30 to 34 most likely to receive a diagnosis. Last year, NHS England pledged to wipe out cervical cancer by 2040. Globally, it is the fourth most common cancer in women, with about 660,000 new cases and 350,000 deaths every year, according to the World Health Organization. The disease develops when abnormal cells appear in the lining of the cervix and grow, eventually coming together as a tumour. If the cells are not caught early, the cancer can spread to other parts of the body. In June, NHS England said that women aged between 25 and 49 who test negative for HPV, meaning they are at very low risk of cervical cancer over the next 10 years, will safely be invited at five-year intervals instead of three. Fiona Osgun, Cancer Research UK's head of health information, said the declining rates were due to a combination of factors. Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion 'We know that people have specific barriers to accessing screening; some of those are practical such as not being able to get an appointment at a time that works for them, but some are more specific to the test itself, such as finding the screening painful or being worried about who's going to be carrying out the test,' Osgun said. 'I think we have just seen a slow decline, which unfortunately can happen even with successful screening programmes. We need to continue to chip away at those misunderstandings and misconceptions some people have regarding cervical screening.' Osgun added that there were various measures people could ask for to make their cervical screening test more comfortable, such as asking for a double appointment or a different-sized speculum. Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.'
Daily Mirror
2 days ago
- Daily Mirror
Young people becoming less likely to get anti-cancer vaccine
Less and less young people are getting a vaccine that could put a stop to one of the most preventable cancers A recent report has highlighted the concerning decline in uptake of a vaccine that could significantly increase chances of avoiding one of the most preventable forms of cancer. Government statistics revealed a continuing drop in HPV vaccinations among young people. The vaccine is typically offered to school pupils aged between 12 and 13 to combat the spread of Human papillomaviruses. These viruses are the primary cause of cervical cancers, with Cancer Research UK stating that 99.8% of these cancer cases are preventable. Only 71.5% of S1 pupils in the 2023/2024 academic year received the vaccine. This represents a decrease from 72.9% the previous year and 73.5% in 2021/2022, indicating a long-term downward trend. A study conducted in 2021 found that rates of cervical cancer fell by nearly 90% among women in their 20s in England who were offered the vaccine when they were aged between 12 and 13. Public Health Scotland 's report on these figures also revealed a worrying disparity between vaccination rates in deprived and affluent communities, despite the vaccine being freely available to eligible people. The most deprived areas saw only 59.9% of S1 pupils vaccinated. In contrast, the least deprived areas reported a vaccination rate of 82.1%. Overall, more girls were receiving the vaccine than boys, and while males aren't at risk of cervical cancers, the vaccine does offer other health benefits like protection against HPV. HPV, a collection of viruses transmitted through sexual contact with an infected person, isn't always harmless; some strains can lead to severe health issues, including an increased risk of cervical cancer. The NHS offers a HPV vaccine that guards against nine types of the virus. Most people under 25 will require just one dose, and it's often referred to as the cervical cancer vaccine by Cancer Research UK. Dr Claire Cameron, from Public Health Scotland (PHS), expressed alarm over the widening disparities in vaccination rates post-pandemic, stating to the BBC: "That's really concerning because this virus can affect everybody and we want everybody to be vaccinated so they can be protected." She believes a fall in vaccine confidence and altered engagement with education and healthcare are behind the decline in vaccinations. Cancer Research UK outlines several groups eligible for the complimentary vaccine: Children aged between 11 and 13 Anyone under 25 who hasn't had their HPV vaccine Men up to age 45 who have sex with men Transgender people under 45 Receiving the vaccine in childhood generally obviates the need for later doses. However, adults are likely to have already come into contact with HPV, diminishing the vaccine's effectiveness. Those not covered by the NHS programme can opt for private vaccination.
Daily Mirror
2 days ago
- Daily Mirror
Kaye Adams taken aback by co-star's 'remarkable' reaction to cancer news
Loose Women star Kaye Adams has been left stunned by her friend Karen MacKenzie's reaction to being diagnosed with breast cancer Kaye Adams of Loose Women has shared her utter astonishment at how her friend coped with a breast cancer diagnosis. Her friend and podcast co-star Karen MacKenzie, discovered an unsettling lump in her breast and immediately sought medical advice. On their How To Be 60 podcast, Karen detailed the swift action taken by the NHS: "That day, I got a mammogram. I got an ultrasound, and I got a biopsy. By the end of the appointment, it was quite clear that there was a cancerous tumour there." But rather than allowing the news to derail her plans, Karen jetted off to Italy for a break before further examination. Upon her return, she underwent an MRI that revealed additional tumours—the initial lump being benign and the opposing breast harbouring the malignant growths. Reflecting on her condition, Karen admitted to overlooking subtle signs: "Now that I see my breasts though, there was a tiny little sort of ripple at the bottom. And I think that's all I could describe it just a little bit of a tuck in the skin, and that's an indication." Despite the intensive treatment and more procedures on the horizon, Karen has maintained a lighthearted and pragmatic stance towards her illness. This strength and resilience have left Kaye incredibly impressed, saying on the podcast: "I have to say, you're handling this incredibly, I really do take my hat off to you. I think you've been remarkable in terms of the way you're dealing with it." Kaye highlighted Karen's remarkable resilience, noting that she even cycled to some of her appointments, showcasing her stoic approach to her condition. Karen recalled discovering lumps in her breast previously — once during breastfeeding and again after being prescribed HRT during menopause — though neither proved to be cancerous. She speculated: "I have no reason to believe this, but in the back of my mind, I think the benign lump here was maybe brought on by HRT. I don't know that, because I stopped HRT as soon as I realised." Medical professionals acknowledge that while there is no concrete evidence directly linking HRT to cancer, it can marginally elevate the risk of certain types, particularly breast cancer, as well as possibly ovarian or womb cancer. The risk is influenced by the type of HRT, treatment duration, and personal factors such as age and family history. Karen confessed she had the occasional "wobble," saying: "I think it was hard," yet she believes she might still be partly in denial about her condition. She expressed her uncertainty: "I don't know whether my head's still in the sand," adding, "I'm not in any pain. I wouldn't think there's anything wrong with me. I don't feel any lumps on that side. It's just like it's happening to somebody else." Kaye has been deeply impressed by her friend's philosophical stance towards the unexpected diagnosis. Meanwhile, Cancer Research UK suggests that maintaining a positive outlook can significantly aid those grappling with the daunting reality of cancer.
